XERS Stock Analysis: Buy, Sell, or Hold?
XERS - Xeris Biopharma Holdings, Inc. Common Stock
Smart Money Accumulation
XERS is down 5.7% this week, but smart money is accumulating calls. Top strike: $7.5 2026-05-15 with 23 OI. Call ratio: 100% View Scanner →
Get Alerted When XERS Hits Your Target Price
Join 10,000+ traders who never miss a move
Interactive Price Chart (1 Month)
Loading historical data...
โ BUY SIGNAL: XERS trading at deep discount. Market pricing in -9.5% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.4x Exit PE.
In-depth Analysis How we analyze
Technical Outlook: Technically, XERS is in a downtrend. The price is approaching resistance at $5.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.14 (+99.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.7%)
- BULLISH: Trading 99.0% below Wall St target ($11.14)
Fair Price Analysis
Support & Resistance Levels
Fundamental Context
Data refreshes hourly during market hours. Next update: 7:42 PM
๐ฅ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Is XERS showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical โฆ |
STRONG BUY
29 analysts |
$89 | 54 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeuticsย Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |